In CMS1, microsatellite stable (MSS) CRC patients with BRAF mutation are associated with a shorter overall survival (OS) compared with BRAF wild type; however, prognostic difference between BRAF mutation or BRAF wild type were not found in MSI CRC patients.24 Here, BRAF is linked to colorectal carcinoma.